Enlaza Therapeutics marries covalent and biologic drugs

While they were both still at Nerio Therapeutics, Sergio Duron brought Sandy Madigan a promising paper from the laboratory of Lei Wang, a chemical biologist at the University of California, San Francisco. It described an unnatural amino acid that can turn a protein into a covalent binder.

“It was pretty clear to us both very early that this was a unique opportunity,” Madigan says. Long before Nerio was acquired by Boehringer Ingelheim, the multitasking serial entrepreneurs started their next project.

Congratulations to Lei Wang, PhD, for his successful technological breakthrough!

more